Home

Capricor Therapeutics, Inc. - Common Stock (CAPR)

8.6550
-0.5250 (-5.72%)
NASDAQ · Last Trade: Apr 8th, 3:21 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
MarketBeat Week in Review – 9/30 - 10/4
A strong jobs report and a temporary settlement of the port strike lifted stocks but inflation and earnings data could set investors up for more volatility
Via MarketBeat · October 5, 2024
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy
Via MarketBeat · September 30, 2024